Cargando…
Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population
OBJECTIVE: Evaluate the clinical and economic consequences of fetal trisomy 21 (T21) screening with non-invasive prenatal testing (NIPT) in high-risk pregnant women. METHODS: Using a decision-analytic model, we estimated the number of T21 cases detected, the number of invasive procedures performed,...
Autores principales: | Song, Ken, Musci, Thomas J., Caughey, Aaron B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa UK Ltd.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3741020/ https://www.ncbi.nlm.nih.gov/pubmed/23356557 http://dx.doi.org/10.3109/14767058.2013.770464 |
Ejemplares similares
-
Sequencing Shorter cfDNA Fragments Decreases the False Negative Rate of Non-invasive Prenatal Testing
por: Xue, Ying, et al.
Publicado: (2020) -
Comparison of the source and prognostic utility of cfDNA in trauma and sepsis
por: Jackson Chornenki, Nicholas L., et al.
Publicado: (2019) -
Novel technologies in cfDNA analysis and potential utility in clinic
por: Li, Jie, et al.
Publicado: (2021) -
The utility of cfDNA in TGCT patient management: a systematic review
por: Krasic, Jure, et al.
Publicado: (2022) -
Microfluidic Technologies for cfDNA Isolation and Analysis
por: Xu, Zheyun, et al.
Publicado: (2019)